Dr. Troy Torgerson
Dr. Troy Torgerson is the Director of Experimental Immunology at the Allen Institute for Immunology and an Affiliate Clinical Professor of Pediatrics at the University of Washington in Seattle. He has a longstanding interest in the molecular basis of immune dysregulation and autoimmunity in humans and in advancing transplant and non-transplant therapies for immune deficiency and immune dysregulation disorders.
Dr. Paul Dellaripa
Dr. Paul Dellaripa is a Rheumatologist at Brigham and Women’s Hospital Boston MA Associate Professor of Medicine Harvard Medical School Boston MA
Dr. Vivian Saper
Dr. Vivian Saper is a faculty member in the Department of Pediatrics, Stanford University School of medicine. She is board certified in Pediatrics, Pediatric Rheumatology and Adult and Pediatric Allergy Asthma and Immunology. Among her other credentials are membership on the FDA’s allergenic product advisory committee and experience as a CLIA certified clinical lab director. For the past several years, she has been the clinical lead of a Stanford led international consortium investigating the recent puzzling emergence of parenchymal lung disease in the setting of Still’s disease. Leisure time is spent with family, travel (pre-COVID), swimming and scuba diving.
Dr. Ron Laxer
Dr. Ron Laxer has been a staff rheumatologist at SickKids since 1984 and is a Professor of Pediatrics and Medicine at the University of Toronto. He has a longstanding interest in rare diseases, and he has been a part of gene discovery of nine unique genetic diseases, including one associated with chronic multifocal osteomyelitis. He is a co-editor of the Textbook of Pediatric Rheumatology, as well as a co-editor of the first edition of the Textbook of Autoinflammation.
Dr. Paul Fortin
Dr. Paul R. Fortin is Full Professor of Medicine at Université Laval and a Clinical Researcher at the Centre de Recherche du CHU de Québec Université Laval since 2011. Dr. Fortin holds a Canada Research Chair in Systemic Autoimmune Rheumatic Diseases (SARDs). He has devoted his career to the understanding of the bio-psycho-social impact of chronic rheumatic diseases. Dr. Fortin is particularly interested in translational research with immediate applications to the care of people with SARDS and in multidimensional preventive and therapeutic interventions to empower people with SARDs and help them take charge of their journeys from illness to wellness.
Dr. Lillian Barra
Dr. Lillian Barra is an Associate Professor in the Department of Medicine, Division of Rheumatology Western University, cross-appointed to the Departments of Microbiology and Immunology, Epidemiology and Biostatistics. She established the first interdisciplinary vasculitis clinic (IVASC) in Southwestern Ontario and is a member of the administrative board for Canadian Vasculitis Network. The focus of her research is understanding the pathogenesis and impact of chronic autoimmune vascular diseases, specifically rheumatoid arthritis (RA)-associated cardiovascular disease and systemic vasculitis. The research is translational involving humanized mouse models of RA and atherosclerosis, biomaker studies, evidence synthesis and observational epidemiologic studies with the establishment and participation in various cohort studies.
Dr. Marc Judson
Dr. Marc Judson is the Chief of Pulmonary and Critical Care Medicine at Albany Medical Center in Albany, New York, USA. He has published over 200 articles concerning sarcoidosis and has been involved in more than 50 sarcoidosis clinical trials.